19 research outputs found

    Aging Mechanisms: Linking oxidative stress, obesity and inflammation

    Get PDF
    Aging cannot be defeated in anyway in the world even having new and advanced technology. But molecular mechanism is a successful method to control aging. Many complex and multifunctional factors are the main cause of aging. It is evident that the studies regarding cellular, genetic, and pathological and biochemical changes are exploring more and more pathways linking various diverse mechanism explaining aging. Implications of basic mechanisms of aging for improving both longevity and quality of life in human needs a clear understanding and takes a long time. However, reactive oxygen species (ROS) indicate a growing body even in the presence of fundamental mechanisms. According to oxidative stress theory, advanced and permanent addition of oxidative damage on critical aspects of aging process instigated by ROS influences. Telomeres theory is another, new aging theory that holds many promising possibilities for the field of anti-aging medicine. The theory was originated from the surge of technological breakthroughs in genetics and genetic engineering. Telomeres have also been found related to obesity. Obesity also leads to accelerated cellular processes. A “causative agent in aging” is considered inflammation that underlies a mechanism showing that for survival acute inflammatory response is necessary but long term exposure to different antigens than predicted by evolution cause low-grade inflammatory status which intern contributes to age-associated illness and death. The condition known as “inflammaging”

    Global, regional, and national sex-specific burden and control of the HIV epidemic, 1990-2019, for 204 countries and territories: the Global Burden of Diseases Study 2019

    Get PDF
    Background: The sustainable development goals (SDGs) aim to end HIV/AIDS as a public health threat by 2030. Understanding the current state of the HIV epidemic and its change over time is essential to this effort. This study assesses the current sex-specific HIV burden in 204 countries and territories and measures progress in the control of the epidemic. Methods: To estimate age-specific and sex-specific trends in 48 of 204 countries, we extended the Estimation and Projection Package Age-Sex Model to also implement the spectrum paediatric model. We used this model in cases where age and sex specific HIV-seroprevalence surveys and antenatal care-clinic sentinel surveillance data were available. For the remaining 156 of 204 locations, we developed a cohort-incidence bias adjustment to derive incidence as a function of cause-of-death data from vital registration systems. The incidence was input to a custom Spectrum model. To assess progress, we measured the percentage change in incident cases and deaths between 2010 and 2019 (threshold >75% decline), the ratio of incident cases to number of people living with HIV (incidence-to-prevalence ratio threshold <0·03), and the ratio of incident cases to deaths (incidence-to-mortality ratio threshold <1·0). Findings: In 2019, there were 36·8 million (95% uncertainty interval [UI] 35·1–38·9) people living with HIV worldwide. There were 0·84 males (95% UI 0·78–0·91) per female living with HIV in 2019, 0·99 male infections (0·91–1·10) for every female infection, and 1·02 male deaths (0·95–1·10) per female death. Global progress in incident cases and deaths between 2010 and 2019 was driven by sub-Saharan Africa (with a 28·52% decrease in incident cases, 95% UI 19·58–35·43, and a 39·66% decrease in deaths, 36·49–42·36). Elsewhere, the incidence remained stable or increased, whereas deaths generally decreased. In 2019, the global incidence-to-prevalence ratio was 0·05 (95% UI 0·05–0·06) and the global incidence-to-mortality ratio was 1·94 (1·76–2·12). No regions met suggested thresholds for progress. Interpretation: Sub-Saharan Africa had both the highest HIV burden and the greatest progress between 1990 and 2019. The number of incident cases and deaths in males and females approached parity in 2019, although there remained more females with HIV than males with HIV. Globally, the HIV epidemic is far from the UNAIDS benchmarks on progress metrics. Funding: The Bill & Melinda Gates Foundation, the National Institute of Mental Health of the US National Institutes of Health (NIH), and the National Institute on Aging of the NIH

    Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

    Get PDF

    Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial

    Get PDF
    Background: Tranexamic acid reduces surgical bleeding and reduces death due to bleeding in patients with trauma. Meta-analyses of small trials show that tranexamic acid might decrease deaths from gastrointestinal bleeding. We aimed to assess the effects of tranexamic acid in patients with gastrointestinal bleeding. Methods: We did an international, multicentre, randomised, placebo-controlled trial in 164 hospitals in 15 countries. Patients were enrolled if the responsible clinician was uncertain whether to use tranexamic acid, were aged above the minimum age considered an adult in their country (either aged 16 years and older or aged 18 years and older), and had significant (defined as at risk of bleeding to death) upper or lower gastrointestinal bleeding. Patients were randomly assigned by selection of a numbered treatment pack from a box containing eight packs that were identical apart from the pack number. Patients received either a loading dose of 1 g tranexamic acid, which was added to 100 mL infusion bag of 0·9% sodium chloride and infused by slow intravenous injection over 10 min, followed by a maintenance dose of 3 g tranexamic acid added to 1 L of any isotonic intravenous solution and infused at 125 mg/h for 24 h, or placebo (sodium chloride 0·9%). Patients, caregivers, and those assessing outcomes were masked to allocation. The primary outcome was death due to bleeding within 5 days of randomisation; analysis excluded patients who received neither dose of the allocated treatment and those for whom outcome data on death were unavailable. This trial was registered with Current Controlled Trials, ISRCTN11225767, and ClinicalTrials.gov, NCT01658124. Findings: Between July 4, 2013, and June 21, 2019, we randomly allocated 12 009 patients to receive tranexamic acid (5994, 49·9%) or matching placebo (6015, 50·1%), of whom 11 952 (99·5%) received the first dose of the allocated treatment. Death due to bleeding within 5 days of randomisation occurred in 222 (4%) of 5956 patients in the tranexamic acid group and in 226 (4%) of 5981 patients in the placebo group (risk ratio [RR] 0·99, 95% CI 0·82–1·18). Arterial thromboembolic events (myocardial infarction or stroke) were similar in the tranexamic acid group and placebo group (42 [0·7%] of 5952 vs 46 [0·8%] of 5977; 0·92; 0·60 to 1·39). Venous thromboembolic events (deep vein thrombosis or pulmonary embolism) were higher in tranexamic acid group than in the placebo group (48 [0·8%] of 5952 vs 26 [0·4%] of 5977; RR 1·85; 95% CI 1·15 to 2·98). Interpretation: We found that tranexamic acid did not reduce death from gastrointestinal bleeding. On the basis of our results, tranexamic acid should not be used for the treatment of gastrointestinal bleeding outside the context of a randomised trial

    TEACHER STUDENTS RELATION AND ITS IMPACT ON ACADEMIC PERFORMANCE OF THE STUDENTS

    No full text
    This quantitative study, conducted with a sample size of 200 students from the district of Pakpatan, aimed to investigate the correlation between positive teacher-student relationships and academic performance, motivation, and engagement. Employing a random sampling method, the research found that a significant majority (70.5%) of respondents observed a positive change in their academic performance following the development of strong relationships with their teachers. Furthermore, 30.5% strongly agreed that positive teacher-student relations directly contributed to improved academic outcomes. Motivation and engagement were also positively impacted, with 72.5% reporting increased motivation due to positive teacher-student relationships

    Graphene based FeO/NiO MOF composites for methanol oxidation reaction

    No full text
    We report a novel bimetallic iron oxide/nickel oxide metal-organic framework (FeO/NiO MOF) that has been synthesized by using two different linkers; 2, 5-dihydroxy terephthalic acid (DHTA) and Pyrazine and also its composites are prepared with reduced graphene oxide from 1 to 5 wt% rGO FeO/NiO MOF and afterwards characterized via several important techniques like FTIR, XRD, SEM and EDX for examination of their morphological and structural properties. The synthesized series of bimetallic MOFs composites were later used as catalyst for methanol oxidation, tested via cyclic voltammetry (CV) in 3 M Methanol and 1 M NaOH on modified GCE. The electrochemical results illustrate that electrocatalytic response of the MOF boosts astonishingly with gradual loadings of rGO from (1-4 wt%) and among all prepared series 4 wt% rGO-FeO/NiO MOF shows the highest current density of 486.14 mA/cm2 at potential of 0.85 V with scan rate of 50 mV/cm2. This superlative response of prepared catalyst makes it a promising catalytic material for methanol oxidation in DMFC

    Pyrolysis of high-ash sewage sludge: Thermo-kinetic study using TGA and artificial neural networks

    Get PDF
    Pyrolysis of high-ash sewage sludge (HASS) is a considered as an effective method and a promising way for energy production from solid waste of wastewater treatment facilities. The main purpose of this work is to build knowledge on pyrolysis mechanisms, kinetics, thermos-gravimetric analysis of high-ash (44.6%) sewage sludge using model-free methods & results validation with artificial neural network (ANN). TG-DTG curves at 5,10 and 20 °C/min showed the pyrolysis zone was divided into three zone. In kinetics, E values of models ranges are; Friedman (10.6–306.2 kJ/mol), FWO (45.6–231.7 kJ/mol), KAS (41.4–232.1 kJ/mol) and Popescu (44.1–241.1 kJ/mol) respectively. ΔH and ΔG values predicted by OFW, KAS and Popescu method are in good agreement and ranged from (41–236 kJ/mol) and 53–304 kJ/mol, respectively. Negative value of ΔS showed the non-spontaneity of the process. An artificial neural network (ANN) model of 2 * 5 * 1 architecture was employed to predict the thermal decomposition of high-ash sewage sludge, showed a good agreement between the experimental values and predicted values (R2 â©Ÿ 0.999) are much closer to 1. Overall, the study reflected the significance of ANN model that could be used as an effective fit model to the thermogravimetric experimental data

    Biodiesel production from marine macroalgae Ulva lactuca lipids using novel Cu-BTC@AC catalyst : Parametric analysis and optimization

    No full text
    The pursuit of renewable fuels for the transportation sector, particularly for combustion engines like diesel, is crucial in reducing greenhouse gas emissions. This study introduces an innovative strategy for biodiesel production utilizing marine macroalgae Ulva lactuca as the primary feedstock, emphasizing sustainability and resource efficiency. Lipids were extracted from the macroalgae via a Soxhlet process and characterized using GC–MS and FTIR to ascertain fatty acid composition and functional groups. The Cu–BTC@AC catalyst, synthesized from the lipid-extracted algae residue via pyrolysis and hydrothermal treatment, underwent characterization using SEM–EDS, XRD, and FTIR techniques. Subsequently, the Cu–BTC@AC catalyst was employed in the transesterification process to efficiently convert the extracted algal lipids into biodiesel, achieving a high yield of 92.56 % under RSM-optimized conditions: 65 °C temperature, 3.96 wt% catalyst amount, 15:1 methanol-to-lipid ratio, and 140 min reaction time. Kinetic and thermodynamic parameters for biodiesel production were calculated as follows: Ea = 33.20 kJ mol−1, ΔH# = 30.39 kJ mol−1, ΔS# = –165.86 J mol−1 K−1, and ΔG# = 86.48 kJ mol−1. GC–MS analysis identified a significant FAME content in the biodiesel, comprising 98.12 % of its composition. Notably, the Cu–BTC@AC catalyst exhibited excellent reusability, maintaining 80.21 % biodiesel yield after the third cycle. Moreover, physicochemical analysis of the biodiesel confirmed its compliance with ASTM D6751 specifications, underscoring its potential as a viable alternative fuel for the transportation sector
    corecore